Varian Medical Systems (VAR) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Reports Results for Fourth Quarter of Fiscal Year 2020
October 27, 2020 5:15 PM EDTPALO ALTO, Calif., Oct. 27, 2020 /PRNewswire/ -- Â
Fourth Quarter 2020 Summary
Oncology Systems gross orders of $1.0 billion, down 8% in dollars or 10% in constant currency 10 Ethos orders received, including 5 in North America and 5 in EMEA One Proton order awarded in North America Total company revenues down 3% in dollars, or 4% in constant currency, to $850 million GAAP operating earnings down 11% at 11.6% of revenues; non-GAAP operating earnings declined 10% at 16.8% of revenues GAAP net earnings per diluted share of $0.83; non-GAAP net earnings per diluted share of $1.12 Cash flows from... More